Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update

Straumann Holding AG (OTCMKTS:SAUHY) saw a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 5,152 shares, a drop of 77.6% from the July 15th total of 23,021 shares. Based on an average daily volume of 79,441 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are sold short.

Straumann Price Performance

Straumann stock traded down $0.04 during midday trading on Friday, reaching $12.55. The stock had a trading volume of 38,266 shares, compared to its average volume of 136,476. The stock’s 50-day simple moving average is $12.55 and its 200 day simple moving average is $11.70. Straumann has a twelve month low of $9.44 and a twelve month high of $13.61.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Barclays reissued an “overweight” rating on shares of Straumann in a research note on Thursday, June 18th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Straumann in a report on Tuesday, June 30th. BMO Capital Markets initiated coverage on Straumann in a research note on Wednesday, July 8th. They issued an “outperform” rating for the company. Citigroup reissued a “sell” rating on shares of Straumann in a research note on Thursday, July 9th. Finally, Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a research note on Tuesday, June 30th. Three equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold”.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.